CORT - Corcept Therapeutics Incorporated

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.18B
Enterprise Value 3986.17M
Trailing P/E 16.90
Forward P/E 18.66
PEG Ratio (5 yr expected) 1-1.14
Price/Sales (ttm)4.58
Price/Book (mrq)4.15
Enterprise Value/Revenue 33.82
Enterprise Value/EBITDA 611.24

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 29.50%
Operating Margin (ttm)33.84%

Management Effectiveness

Return on Assets (ttm)19.41%
Return on Equity (ttm)30.43%

Income Statement

Revenue (ttm)258.42M
Revenue Per Share (ttm)2.24
Quarterly Revenue Growth (yoy)12.40%
Gross Profit (ttm)246.03M
EBITDA 87.74M
Net Income Avi to Common (ttm)76.22M
Diluted EPS (ttm)0.61
Quarterly Earnings Growth (yoy)4.70%

Balance Sheet

Total Cash (mrq)186.9M
Total Cash Per Share (mrq)1.63
Total Debt (mrq)1.52M
Total Debt/Equity (mrq)0.53
Current Ratio (mrq)6.34
Book Value Per Share (mrq)2.49

Cash Flow Statement

Operating Cash Flow (ttm)104.92M
Levered Free Cash Flow (ttm)80.82M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.28
52-Week Change 3-43.93%
S&P500 52-Week Change 34.92%
52 Week High 320.00
52 Week Low 39.14
50-Day Moving Average 311.66
200-Day Moving Average 312.53

Share Statistics

Avg Vol (3 month) 3853.86k
Avg Vol (10 day) 3667.16k
Shares Outstanding 5114.86M
Float 103.6M
% Held by Insiders 19.71%
% Held by Institutions 179.82%
Shares Short (Apr 30, 2019) 424M
Short Ratio (Apr 30, 2019) 435.63
Short % of Float (Apr 30, 2019) 431.36%
Short % of Shares Outstanding (Apr 30, 2019) 420.91%
Shares Short (prior month Mar 29, 2019) 425.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A